Polymerase Chain Reactions (PCR) Devices, Reagents and Uses Market Report 2025

This Polymerase Chain Reactions (PCR) Devices, Reagents and Uses market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The polymerase chain reactions (PCR) devices, reagents and uses market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.51 billion in 2025 at a compound annual growth rate (CAGR) of 5%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, increasing demand for clinical diagnostic services, growing demand for personalized medicine, increasing adoption of PCR in research and development.

The polymerase chain reactions (PCR) devices, reagents and uses market size is expected to see strong growth in the next few years. It will grow to $9.01 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to COVID-19 and infectious disease monitoring, cancer diagnostics and liquid biopsies, agricultural and environmental applications, expansion of pharmacogenomics, genomic research advancements. Major trends in the forecast period include digital PCR, multiplex PCR, next-generation sequencing (NGS) integration, miniaturization and portable devices, AI and data analytics, automation, and robotics.

The rising prevalence of infectious diseases worldwide is fueling growth in the market for polymerase chain reaction (PCR) devices, reagents, and applications. PCR devices are essential in clinical laboratories for detecting infectious diseases. According to a World Health Organization report, infectious diseases claim approximately 17 million lives each year, and 30 new infectious diseases have emerged over the past 20 years. For example, the UK Health Security Agency reported that England saw 368 measles cases in 2023 - nearly seven times the 53 cases recorded in 2022. Such increases in infectious disease cases are driving the demand for clinical diagnostic services, thus boosting the PCR devices, reagents, and applications market.

The burgeoning pharmaceutical industry is poised to catalyze growth in the PCR devices, reagents, and applications market. As a key player in healthcare, the pharmaceutical sector is heavily involved in drug research, development, manufacturing, and marketing. Its engagement in drug development, diagnostics, quality control, and personalized medicine fosters diverse applications for PCR devices and reagents. In 2021, Americans spent $576.9 billion on prescription drugs, with an anticipated expenditure of $605 to $635 billion on medical care in the US by 2025, as reported by Cross River Therapy. The pharmaceutical industry's expansion is thus a driving force behind the growth of PCR devices, reagents, and their multifaceted uses.

Companies in the PCR devices and reagents market are increasingly directing attention toward Digital PCR due to its heightened accuracy compared to conventional methods. Digital PCR offers a comprehensive evaluation of nucleic acids without relying on standard curves, expanding upon traditional techniques. Leading entities investing in digital polymerase chain reaction technology include BioRad Technologies, Atlas Genetics, OriGene Technologies, STST-Diagnostica, Ugen Tec, and Genesis Healthcare Company.

Leading companies in the PCR devices, reagents, and applications market are prioritizing the development of advanced diagnostic tools to enhance the accuracy and speed of genetic testing, enable early disease detection, and support research across healthcare, environmental monitoring, and food safety sectors. Advanced diagnostic tools are highly specialized technologies that improve diagnostic accuracy and efficiency, allowing healthcare providers to make well-informed patient care decisions. For instance, in August 2023, Gold Standard Diagnostics, a Germany-based producer of diagnostic test kits, instruments, and reagents, introduced the DNAllergen RT-PCR kits. These molecular tools utilize real-time PCR technology to detect specific allergens in food products with high sensitivity and specificity, identifying allergens such as almond, celery, and fish that are difficult to detect using conventional methods. Compatible with various DNA extraction techniques and PCR equipment, these kits offer versatility for allergen testing laboratories, ensuring reliable compliance with food safety standards.

Major companies operating in the polymerase chain reactions (PCR) devices, reagents and uses market include Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMérieux S.A., Agilent Technologies Inc., QIAGEN N.V., Siemens Healthcare GmbH (Siemens AG), Fluidigm Corporation, SYGNIS Pharma AG, Takara Bio Inc., Cepheid, Lontech Laboratories, Eppendorf India Private Limited, GE Healthcare, Kapa Biosystems, Maxim Biomedical Inc., Promega Corporation, RainDance Technologies Inc., Affymetrix Inc., Beckman Coulter Inc., Enzo Life Sciences Inc., Roche Diagnostics GmbH, Merck KGaA, Danaher Corporation, Stilla Technologies, Meridian Bioscience Inc., BioFire Diagnostics LLC, Luminex Corporation, GenMark Diagnostics Inc.

Polymerase Chain Reaction (PCR) devices and reagents serve the purpose of enabling scientists to replicate multiple copies of specific DNA segments. Within PCR, a targeted portion of the genome undergoes amplification using short synthetic DNA fragments known as primers, resulting in the amplification of the selected segment through multiple rounds of DNA synthesis.

The primary products within PCR devices and reagents include instruments, reagents, and consumables. Instruments refer to tools or devices designed for specific tasks. Varieties of instruments utilized include standard PCR, rt-PCR (reverse transcription PCR), and digital PCR. These products find application across diverse end-users such as the pharmaceutical and biotechnology industries, clinical diagnostics labs, hospitals, academic institutions, and research organizations.

The polymerase chain reactions (PCR) devices and reagents market research report is one of a series of new reports that provides polymerase chain reactions (PCR) devices and reagents market statistics, including polymerase chain reactions (PCR) devices and reagents industry global market size, regional shares, competitors with a polymerase chain reactions (PCR) devices and reagents market share, detailed polymerase chain reactions (PCR) devices and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reactions (PCR) devices and reagents industry. This polymerase chain reaction (PCR) devices and reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the polymerase chain reactions (PCR) devices and reagents market in 2024. Western Europe was the second-largest region in the global polymerase chain reactions (PCR) devices and reagents market report. The regions covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the polymerase chain reactions (PCR) devices, reagents and uses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The polymerase chain reactions (PCR) devices and reagents market consists of sales of conventional PCR machines, qPCR, reverse transcription PCR, nested PCR, hot start PCR, and digital PCR devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.